Cargando…
Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK Inhibitor
DNA-dependent protein kinase (DNA-PK), a driver of the non-homologous end-joining (NHEJ) DNA damage response pathway, plays an instrumental role in repairing double-strand breaks (DSB) induced by DNA-damaging poisons. We evaluate ZL-2201, an orally bioavailable, highly potent, and selective pharmaco...
Autores principales: | Lal, Shruti, Bhola, Neil E., Sun, Bee-Chun, Chen, Yuping, Huang, Tom, Morton, Vivian, Chen, Kevin X., Xia, Shanghua, Zhang, Haoyu, Parikh, Nehal S., Ye, Qiuping, Veiby, O. Petter, Bellovin, David I., Ji, Yuhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473160/ https://www.ncbi.nlm.nih.gov/pubmed/37663435 http://dx.doi.org/10.1158/2767-9764.CRC-23-0304 |
Ejemplares similares
-
ZL-1211 Exhibits Robust Antitumor Activity by Enhancing ADCC and Activating NK Cell–mediated Inflammation in CLDN18.2-High and -Low Expressing Gastric Cancer Models
por: Konno, Hiroyasu, et al.
Publicado: (2022) -
Effect of Micro-Scale Er on the Microstructure and Fluidity of ZL205A Alloy
por: Guo, Tingbiao, et al.
Publicado: (2019) -
Metabolism and Pharmacokinetic Study of the Boron-Containing Prodrug of Belinostat (ZL277), a Pan HDAC Inhibitor with Enhanced Bioavailability
por: Zhang, Changde, et al.
Publicado: (2019) -
PB2201: THYMUS DEVELOPMENT IN CONGENITAL HEART DISEASES
por: Bódi, I., et al.
Publicado: (2022) -
Strategies to distinguish new synthetic cannabinoid FUBIMINA (BIM-2201) intake from its isomer THJ-2201: metabolism of FUBIMINA in human hepatocytes
por: Diao, Xingxing, et al.
Publicado: (2016)